SERGEY LIPKO: Open Payments
NPI 1972137966 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,412 in 82 payments from 22 companies in 2025. Trend: 2023 $1,394 · 2024 $1,168 · 2025 $1,412
Food & beverage: $1,412
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 22 | $160 |
| Endo USA, Inc. | 8 | $150 |
| Ferring Pharmaceuticals Inc. | 7 | $149 |
| ABBVIE INC. | 5 | $105 |
| Janssen Biotech, Inc. | 4 | $94 |
| Dendreon Pharmaceuticals LLC | 3 | $84 |
| Sumitomo Pharma America, Inc. | 5 | $83 |
| UROGEN PHARMA, INC. | 3 | $77 |
| Merck Sharp & Dohme LLC | 3 | $71 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $64 |
Products named: Luja Coude, ADSTILADRIN, BOTOX, Xtandi, ERLEADA, AVEED, PROVENGE, GEMTESA.
Industry payments across SC — which companies pay providers there.
